drugset / Trial / NCT04374318
Comparison Between Intrathecal and Intravenous Dexmedetomidine
RandomizedCrossoverQuadruple-blindTreatment
Summary
A prospective, randomized, comparative controlled clinical trial, aiming to compare the use of intrathecal dexmedetomidine by intravenous dexmedetomidine in concern of the first request to analgesia. The secondary end-points were the total postoperative analgesic consumption as well as the VAS.
Timeline
- Start
- 2019-03-01
- Primary completion
- 2019-10-30
- Completion
- 2020-03-30
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Comparator | Dexmedetomidine | Other / unclassified | 0.75 ug/kg | Intrathecal |
| Comparator | Dexmedetomidine | Other / unclassified | 5 ug | Intrathecal |
Indications
No indication recorded.